A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/00 (2006.01) A61K 38/45 (2006.01) A61P 35/00 (2006.01) A61P 37/04 (2006.01)
Patent
CA 2748996
This invention relates to proteins or peptides which elicit T cell mediated immunity, and to cancer vaccines and compositions for anti-cancer treatment comprising such proteins or peptide fragments. This invention also relates to pharmaceutical compositions comprising the proteins or peptides and methods for generating T lymphocytes capable of recognising and destroying tumour cells in a mammal. More specifically, a telomerase protein or peptide for use in a method of treatment or prophylaxis of cancer is provided. In a preferred embodiment, the method comprises generating a T cell response against telomerase.
Eriksen Jon Amund
Gaudernack Gustav
Gjertsen Marianne Klemp
Moeller Mona
Saeboe-Larsen Stein
Fetherstonhaugh & Co.
Gemvax As
LandOfFree
Antigenic peptides derived from telomerase does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antigenic peptides derived from telomerase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antigenic peptides derived from telomerase will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1357119